Congressman Scott Garrett

Representing the 5th District of New Jersey

Media Center

Latest News

Oct 11, 2016 Press Release

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05) issued the following statement after the U.S. Court of Appeals for the D.C. Circuit ruled that the structure of the Consumer Financial Protection Bureau (CFPB) is unconstitutional:

Sep 28, 2016 Press Release

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05) issued the following statement on the passing of Israeli President Shimon Peres:

Issues:
Sep 26, 2016 In The News

Imagine if the Treasury Secretary had to live by new rules for banks.

Sep 23, 2016 Press Release

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05) issued the following statement after voting for H.R. 5931, the Prohibiting Future Ransom Payments to Iran Act, to make sure the United States never pays ransom to Iran ever again. Garrett is a co-sponsor of this legislation:

Sep 22, 2016 Press Release

WASHINGTON, D.C. – Capital Markets and Government-Sponsored Enterprises Subcommittee Chairman Scott Garrett (NJ-05) delivered the following remarks at a hearing entitled, “Examining the Agenda of Regulators SROs, and Standard-Setters for Accounting, Auditing, and Municipal Securities”:

Sep 22, 2016 Press Release

WASHINGTON, D.C. – Rep. Scott Garrett, (NJ-05) Chairman of the subcommittee on Capital Markets and Government-Sponsored Enterprises,  delivered the following opening remarks at Financial Services Committee hearing entitled, “The Annual Report of the Financial Stability Oversight Council” featuring Treasury Secretary Jack Lew:

Sep 21, 2016 Press Release

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05) issued the following statement after the House passed H.R. 5859, the Community Counterterrorism Preparedness Act, a bill that Garrett co-sponsored and supported:

Issues:
Sep 21, 2016 Press Release

WASHINGTON, D.C. – Capital Markets and Government-Sponsored Enterprises Subcommittee Chairman Scott Garrett (NJ-05) delivered the following remarks at a hearing entitled, “Corporate Governance:  Fostering a System that Promotes Capital Formation and Maximizes Shareholder Value”:

Sep 21, 2016 Press Release

WASHINGTON, D.C. – Rep. Scott Garrett (NJ-05) issued the following statement after the Food and Drug Administration (FDA) this week announced the accelerated approval for a new treatment for Duchenne muscular dystrophy:

Issues: